Characteristics | Control | SSRIs | Mirtazapine | P | ||
---|---|---|---|---|---|---|
R | NR | R | NR | |||
N | 10 | 19 | 16 | 22 | 21 | Â |
Age, mean ± SD, year | 67.4 ± 6.7 | 65.9 ± 12.3 | 62.4 ± 10.2 | 66.4 ± 8.8 | 66.8 ± 9.4 | 0.884 |
Gender, M:F, n | 3:7 | 6:13 | 4:12 | 6:16 | 6:15 | 0.996 |
HAM-D score, mean ± SD |  | 19.0 ± 3.11 | 20.6 ± 2.76 | 18.2 ± 2.64 | 20.2 ± 3.79 | 0.320 |
Onset age, mean ± SD, year |  | 56.4 ± 14.2 | 57.6 ± 9.66 | 56.5 ± 15.6 | 55.1 ± 14.5 | 0.573 |
No. of episode, mean ± SD |  | 2.58 ± 1.92 | 1.75 ± 0.86 | 2.64 ± 2.06 | 3.33 ± 2.83 | 0.376 |
Duration of current episode, mean ± SD, m |  | 4.21 ± 3.60 | 9.56 ± 7.89 | 3.86 ± 3.12 | 7.19 ± 6.59 | 0.105 |
Antidepressant used, n (%) | Â | Â | Â | Â | Â | 0.956 |
 Escitalopram |  | 2 (10.5) | 1 (6.3) |  |  |  |
 Fluoxetine |  | 8 (42.1) | 9 (56.3) |  |  |  |
 Paroxetine |  | 5 (26.3) | 3 (18.8) |  |  |  |
 Sertraline |  | 4 (21.1) | 3 (18.8) |  |  |  |
 Mirtazapine |  |  |  | 22 | 21 |  |